Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New speech therapy trial aims to help korean Parkinson's patients speak clearly

NCT ID NCT06593860

Symptom relief Sponsor: Florida State University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a remote speech therapy program for 32 Korean-speaking people with Parkinson's disease and their families. The therapy includes 16 sessions over four weeks, plus daily home practice, to improve speech clarity. The goal is to see if this culturally adapted approach can help patients communicate better and improve their quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Remote speech rehabilitation (speech therapy and family education/training)
What this could lead to
If successful, this could lead to a culturally tailored speech therapy model that improves communication for Korean-speaking Parkinson's patients.
What could go wrong
This is a small, early-stage trial with only 32 participants, so results may not apply to all patients. The therapy requires high-speed internet and daily practice, which may be challenging for some.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 32 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2024

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Medical diagnosis of PD * No history of other neurological disease * Native speaker of Korean * Age between 25 and 85 * Diagnosis of dysarthria secondary to PD from an SLP * Self-reported typical hearing * Access to high-speed internet for therapy sessions Exclusion Criteria: * A score of 23 or below on the Korean Montreal Cognitive Assessment * Evidence of voice-speech disorders not-related to PD * Received speech therapy for PD-related problems in the past one year * Have no family members to participate in the project.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dysarthria are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Dysarthria Parkinson disease Psychological Well-Being Speech speech disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dysarthria Parkinson disease

Contacts and locations

Locations

  • Florida State University

    Tallahassee, Florida, 32309, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.